logo BDSP

Base documentaire

  1. Fulltext. The reporting sensitivities of two passive surveillance systems for vaccine adverse events.

    Article - En anglais


    To evaluate reporting sensitivities for vaccine adverse events, reporting rates were estimated by dividing the number of events reported to the Monitoring System for Adverse Events Following Immunization and the Vaccine Adverse Event Reporting System in a given period by the number of doses administered or distributed during the same period.

    Reporting sensitivity was calculated as the ratio of the rates at which events were reported to each passive surveillance system (numerator) and occurred in controlled studies (denominator).

    Reporting sensitivities were generally better in the public sector than the private sector.

    The significant underreporting of known outcomes, together with the nonspecific nature of most adverse event reports, highlights the limitations of passive surveillance systems in assessing the incidence of vaccine adverse events.

    Mots-clés Pascal : Surveillance, Pharmacovigilance, Complication, Vaccin, Etats Unis, Homme, Déclaration, Amérique du Nord, Amérique

    Mots-clés Pascal anglais : Surveillance, Pharmacovigilance, Complication, Vaccine, United States, Human, North America, America

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 96-0045999

    Code Inist : 002B30A03C. Création : 01/03/1996.